Home 2023

Therapeutics

Forwarding Allogeneic Therapies
Bioprocessing

Forwarding Allogeneic Therapies

John Sterling -
0
Oncolytic Virus Improves Survival in Glioblastoma Trial
Cancer

Oncolytic Virus Improves Survival in Glioblastoma Trial

Sophia Ktori -
0
Increasing Access to Cell Therapies
Bioprocessing

Increasing Access to Cell Therapies

John Sterling -
0
Analytical Technologies Evolve with Cell Therapies
Bioprocessing

Analytical Technologies Evolve with Cell Therapies

John Sterling -
0
Spatial Proteomics Maps Head and Neck Tumors, Targets Biomarkers
News

Spatial Proteomics Maps Head and Neck Tumors, Targets Biomarkers

Julianna LeMieux, PhD -
0
“Itch Cytokine” Contributes to Allergy via Neuroimmune Pathway
Featured

“Itch Cytokine” Contributes to Allergy via Neuroimmune Pathway

Sophia Ktori -
0
Meeting on the Mesa: Without Ethics, Cell and Gene Therapy Will Fail
Drug Discovery

Meeting on the Mesa: Without Ethics, Cell and Gene Therapy Will Fail

Jonathan D Grinstein, PhD -
0
Engineered Probiotic Bacteria Colonize Tumors, Attract CAR-T Cells
Cancer

Engineered Probiotic Bacteria Colonize Tumors, Attract CAR-T Cells

Sophia Ktori -
0
StockWatch: Novo Nordisk Shares Soar as Ozempic Aces Phase III CKD Trial
Drug Discovery

StockWatch: Novo Nordisk Shares Soar as Ozempic Aces Phase III CKD Trial

Alex Philippidis -
0
Meeting on the Mesa: How to Bring Cell and Gene Therapies to Market
Bioprocessing

Meeting on the Mesa: How to Bring Cell and Gene Therapies to Market

Jonathan D Grinstein, PhD -
0
123...754Page 1 of 754
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.